Moving Annual report 2016 Department of Nuclear Medicine & PET-Centre, Aarhus University Hospital Department of Nuclear Medicine & PET-Centre 2016 Nørrebrogade Building 3, Nørrebrogade , Building 10 Skejby TABLE OF CONTENTS Table of contents Preface ............................................................................................................................................................................................................................................................................................................. 1 Organisation.................................................................................................................................................................................................................................................................................................. 3 Department adresses........................................................................................................................................................................................................................................................................ 3 Organisation chart .............................................................................................................................................................................................................................................................................. 3 Staff .............................................................................................................................................................................................................................................................................................................. 4 Equipment ...................................................................................................................................................................................................................................................................................................... 7 Excellence – from molecule to man ............................................................................................................................................................................................................................................... 8 Radiochemistry ............................................................................................................................................................................................................................................................................................ 9 Radiochemistry - PET ........................................................................................................................................................................................................................................................................ 9 Radiochemistry – Nuclear medicine..................................................................................................................................................................................................................................... 12 Neuroscience ............................................................................................................................................................................................................................................................................................ 14 Molecular imaging of brain disorders .................................................................................................................................................................................................................................. 14 Clinical nuclear medicine examinations in brain disorders ................................................................................................................................................................................... 14 Research in Parkinson’s disease.............................................................................................................................................................................................................................................. 16 Research in Alzheimer’s disease............................................................................................................................................................................................................................................. 17 Imaging glutamate ion channel activation ..................................................................................................................................................................................................................... 18 Research in REM sleep behavior disorder and prodromal Parkinson’s disease ........................................................................................................................................ 19 Nuclear cardiology ................................................................................................................................................................................................................................................................................ 21 Nuclear oncology ................................................................................................................................................................................................................................................................................... 23 PSMA PET/CT in prostate cancer ........................................................................................................................................................................................................................................... 23 Metabolism.................................................................................................................................................................................................................................................................................................. 25 Metabolism from a PET perspective ..................................................................................................................................................................................................................................... 25 Inflammation.............................................................................................................................................................................................................................................................................................. 28 PET/CT and rheumatic diseases: Expanding ........................................................................................................................................................................................................... 28 Pediatric nuclear medicine ............................................................................................................................................................................................................................................................... 32 Liver PET ........................................................................................................................................................................................................................................................................................................ 34 Quantitative Imaging of Liver Functions by PET ............................................................................................................................................................................................................ 34 "Highlights 2016 ....................................................................................................................................................................................................................................................................................... 36 Radionuclide therapy ........................................................................................................................................................................................................................................................................... 43 Neuroendocrine tumours ............................................................................................................................................................................................................................................................ 43 Hepatic malignancies ................................................................................................................................................................................................................................................................... 44 Thyroid disease ................................................................................................................................................................................................................................................................................. 45 Training and teaching .......................................................................................................................................................................................................................................................................... 47 Medical doctors/specialists